These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19332709)

  • 1. Predictive biomarkers: identification and verification.
    Yeatman TJ
    J Clin Oncol; 2009 Jun; 27(17):2743-4. PubMed ID: 19332709
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial methods to discover and validate predictive markers for treatment response in cancer.
    Paik S
    Biotechnol Annu Rev; 2003; 9():259-67. PubMed ID: 14650930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
    Hansen AR; Siu LL
    JAMA Oncol; 2016 Jan; 2(1):15-6. PubMed ID: 26562503
    [No Abstract]   [Full Text] [Related]  

  • 4. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
    El Bairi K; Atanasov AG; Amrani M; Afqir S
    Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Precision Oncology for the Treatment of Solid Tumors.
    Klute KA
    Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of predictive biomarkers in oncology drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2016 Aug; 16(8):807-9. PubMed ID: 27282189
    [No Abstract]   [Full Text] [Related]  

  • 7. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular pathology in therapeutics: where are we now, and where are we going?
    Harrison DJ; Faratian D
    Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticipating designer drug-resistant cancer cells.
    Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
    Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemoresponse assays as predictive markers.
    Korn EL; Freidlin B
    Br J Cancer; 2015 Feb; 112(4):621-3. PubMed ID: 25584494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and biomarkers in clinical trials for drug development.
    Lee JM; Han JJ; Altwerger G; Kohn EC
    J Proteomics; 2011 Nov; 74(12):2632-41. PubMed ID: 21570499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of the parameters indicating response to drug therapy: from regression to complete control of the disease and the symptoms].
    Cascinu S; Camisa R; D'Angelo A; Salvagni S
    Tumori; 2002; 88(6):A7-9. PubMed ID: 12597158
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptor.
    Carden CP; Molife LR; de Bono JS
    Mol Cancer Ther; 2009 Aug; 8(8):2077-8. PubMed ID: 19671737
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era).
    Franco R; Cantile M
    Curr Drug Targets; 2017; 18(1):2-3. PubMed ID: 27991404
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biomarker strategy for cancer treatment and cancer drug development].
    Koizumi F
    Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):105-10. PubMed ID: 18689960
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019.
    Chen EY; Haslam A; Prasad V
    JAMA Intern Med; 2020 Jun; 180(6):912-914. PubMed ID: 32338703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do predictive signatures really predict response to cancer chemotherapy?
    Borst P; Wessels L
    Cell Cycle; 2010 Dec; 9(24):4836-40. PubMed ID: 21150277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US Food and Drug Administration approves first cancer treatment for any solid tumors with specific biomarker.
    Cancer; 2017 Oct; 123(19):3652-3653. PubMed ID: 28940329
    [No Abstract]   [Full Text] [Related]  

  • 20. Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment.
    Bernier J; Bourhis J
    Ann Oncol; 2005 Nov; 16(11):1722. PubMed ID: 16087695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.